Alina Boteanu - Concepedia

Author

Alina Boteanu

Hospital Universitario Ramón y Cajal ORCID

Also Known As

A Boteanu, A L Boteanu, A. Boteanu, A. Lucica Boteanu, A.L. Boteanu, AL Boteanu, Agustin Remesal, Alina Boteanu, Alina L Boteanu, Alina L. Boteanu

135

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Ramón y Cajal Hospital General Universitario Gregorio Marañón Hospital Universitari Germans Trias i Pujol Istituto Giannina Gaslini Hospital Universitario de Gran Canaria Doctor Negrín

About

Alina Boteanu is an author at Hospital Universitario Ramón y Cajal specializing in medicine, rheumatology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	661
2	Immunology	4	4	292
3	Epidemiology	3	3	451
4	Public Health	2	2	253
5	Health Policy	1	1	107

Alina Boteanu

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study Alessandro Consolaro, Gabriella Giancane, Alessandra Alongi, The Lancet Child & Adolescent Health RheumatologyChild HealthChildhood ArthritisPediatricsOsteoarthritis	2019	198
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial Hermine I. Brunner, Carlos Abud‐Mendoza, Diego Oscar Viola, Annals of the Rheumatic Diseases	2020	179
Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus Íñigo Rúa‐Figueroa, J. Lόpez-Longo, María Galindo-Izquierdo, Seminars in Arthritis and Rheumatism Severe InfectionsAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupus	2017	146
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study Jesus Loarce‐Martos, Antía García Fernández, F. López-Gutiérrez, Rheumatology International RheumatologyAutoimmune DiseaseHigh RatesRheumatic DiseasesSevere Disease	2020	117
Cardiovascular Events in Systemic Lupus Erythematosus Antonio Fernández‐Nebro, Íñigo Rúa‐Figueroa, Francisco Javier López-Longo, Medicine Vascular DiseaseCoronary Artery DiseaseStrokePublic HealthAtherosclerosis	2015	107
Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases Javier Bachiller‐Corral, Alina Boteanu, María Jesús García-Villanueva, The Journal of Rheumatology	2021	66
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial Athimalaipet V Ramanan, Pierre Quartier, Nami Okamoto, The Lancet RheumatologyJuvenile Idiopathic ArthritisPediatricsOsteoarthritisSafety Trial	2023	64
Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases Daniel Clemente, Clara Udaondo, Jaime de Inocencio Arocena, Pediatric Rheumatology	2021	35
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis Nicolino Ruperto, Hermine I. Brunner, Athimalaipet V Ramanan, Lara D. Veeken	2021	34
Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries‐Based Study Íñigo Rúa‐Figueroa, M. Fernández Castro, José Luís Andreu, Arthritis Care & Research	2016	31

Page 1